Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Ogilvy

European venture funding for the life science sector

Trends in healthcare

- PMLiVE

Effective sales performance

The role of targeting

- PMLiVE

Pharma’s coral reef

Who competes with whom has changed, which means how to compete must change too

- PMLiVE

So, you think you can multitask?

Sparking change in pharma

- PMLiVE

The cultural construction of illness

Why understanding this concept is  essential for pharmaceutical marketers

- PMLiVE

Boosting pharma’s metabolic rate

How using more diversity at the top can speed-up change

- PMLiVE

Change in the pharma industry is inevitable

But successul change isn't

Breathing data

Novartis’ new CEO-designate points to an evolutionary leap

Content Shock

Is your content good enough to power your multi-channel marketing?

Content shock is the time when increasing volumes of content intersect our limited human capacity to consume it.

An agency called Owen

Brexit implications for UK pharma legislation

What are the potential options and outcomes of the negotiations?

- PMLiVE

Macron, Merkel and May: implications of the 2017 elections for the life science industry

Political instability and policy continuity in Europe’s biggest economies mean a worsening commercial environment stacked with uncertainty

AI’s potential in the pharma life cycle

At a time that the future of life sciences is being hotly debated, the opportunity for the industry to refine and expand its role is an important one to take...

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links